UBS AM’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.6M | Buy |
201,451
+48,293
| +32% | +$2.78M | ﹤0.01% | 1286 |
|
2025
Q1 | $8.92M | Buy |
153,158
+13,767
| +10% | +$802K | ﹤0.01% | 1280 |
|
2024
Q4 | $11.2M | Buy |
139,391
+22,931
| +20% | +$1.85M | ﹤0.01% | 1196 |
|
2024
Q3 | $9.33M | Buy |
116,460
+3,083
| +3% | +$247K | ﹤0.01% | 1261 |
|
2024
Q2 | $6.93M | Buy |
113,377
+61,301
| +118% | +$3.74M | ﹤0.01% | 1313 |
|
2024
Q1 | $2.57M | Buy |
52,076
+7,853
| +18% | +$388K | ﹤0.01% | 1553 |
|
2023
Q4 | $1.85M | Buy |
44,223
+12,086
| +38% | +$507K | ﹤0.01% | 1732 |
|
2023
Q3 | $1.05M | Buy |
32,137
+18,552
| +137% | +$609K | ﹤0.01% | 1936 |
|
2023
Q2 | $386K | Hold |
13,585
| – | – | ﹤0.01% | 2399 |
|
2023
Q1 | $386K | Buy |
13,585
+1,257
| +10% | +$35.7K | ﹤0.01% | 2399 |
|
2022
Q4 | $512K | Buy |
+12,328
| New | +$512K | ﹤0.01% | 2170 |
|